Ordinary Rebalance | Solactive Global Healthcare Exposure Index | Effective Date 8th February 2024
In the ordinary rebalance, the following composition will be implemented effective open 08.02.2024:
ABBVIE INC |
AGC INC |
AIR WATER INC |
ALFRESA HOLDINGS CORP ORD |
AMGEN INC |
ASAHI KASEI CORP |
ASTELLAS PHARMA INC |
CANON INC |
CORNING INC |
CVS HEALTH CORP |
GILEAD SCIENCES INC |
GSK PLC |
HIKMA PHARMACEUTICALS PLC |
JOHNSON & JOHNSON |
MEDIBANK PRIVATE |
MEDTRONIC PLC |
MEIJI HOLDINGS CO LTD |
MERCK & CO. INC. |
NOVARTIS AG |
ONO PHARMACEUTICAL CO LTD ORD |
PROCTER & GAMBLE CO |
RECKITT BENCKISER GROUP PLC |
RECORDATI SPA |
ROCHE HOLDING AG |
SBI HOLDINGS INC ORD |
SEKISUI CHEMICAL CO LTD ORD |
SOMPO HOLDINGS INC |
SONIC HEALTHCARE (TECH AUST) ORD |
TAKEDA PHARMACEUTICAL |
TORAY INDUSTRIES INC ORD |